Showing results (71-80 of 127) with videos related to
Sort By:
Pageof 13
Frontiers in Psychology|May 2, 2018
Metabolic and Electrophysiological Changes Associated to Clinical Improvement in Two Severely Traumatized Subjects Treated With EMDR-A Pilot StudyMarco Pagani, Gianluca Castelnuovo, Andrea Daverio, et al.Clinical Neurology and Neurosurgery|February 7, 2018
Dopaminergic involvement in a drummer with focal dystonia: A case studyTommaso Schirinzi, Simona Scalise, Giulia Di Lazzaro, et al.Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|September 27, 2018
Does fatigue in Parkinson's disease correlate with autonomic nervous system dysfunction?Enrica Olivola, Livia Brusa, Camilla Rocchi, et al.Oncology Letters|January 27, 2015
Brain metabolic changes in Hodgkin disease patients following diagnosis and during the disease course: An 18F-FDG PET/CT studyAgostino Chiaravalloti, Marco Pagani, Maria Cantonetti, et al.Medicine|September 16, 2016
Is cerebral glucose metabolism related to blood-brain barrier dysfunction and intrathecal IgG synthesis in Alzheimer disease?: A 18F-FDG PET/CT studyAgostino Chiaravalloti, Alessandro Fiorentini, Ursini Francesco, et al.Dementia and Geriatric Cognitive Disorders Extra|May 20, 2016
Comparison between Early-Onset and Late-Onset Alzheimer's Disease Patients with Amnestic Presentation: CSF and (18)F-FDG PET StudyAgostino Chiaravalloti, Giacomo Koch, Sofia Toniolo, et al.Journal of Neurology|September 14, 2017
Hypothalamic dysfunction is related to sleep impairment and CSF biomarkers in Alzheimer's diseaseClaudio Liguori, Agostino Chiaravalloti, Marzia Nuccetelli, et al.European Journal of Nuclear Medicine and Molecular Imaging|February 25, 2014
Factors affecting intrapatient liver and mediastinal blood pool ¹⁸F-FDG standardized uptake value changes during ABVD chemotherapy in Hodgkin's lymphomaAgostino Chiaravalloti, Roberta Danieli, Paolo Abbatiello, et al.Medicine|August 15, 2014
Initial staging of Hodgkin's disease: role of contrast-enhanced 18F FDG PET/CTAgostino Chiaravalloti, Roberta Danieli, Cristiana Ragano Caracciolo, et al.Oncology Letters|November 30, 2016
Evaluation of recurrent disease in the re-staging of colorectal cancer by 18F-FDG PET/CT: Use of CEA and CA 19-9 in patient selectionAgostino Chiaravalloti, Alessandro Fiorentini, Erika Palombo, et al.Pageof 13